Details

Autor(en) / Beteiligte

• Mohamed Khosroshahi, Leila
• Rokni, Mohsen
• Mokhtari, Tahmineh
• Noorbakhsh, Farshid

Titel

Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview

Ist Teil von

• International immunopharmacology, 2021-04, Vol.93, p.107364-107364, Article 107364

Ort / Verlag

Netherlands: Elsevier B.V

Erscheinungsjahr

2021

Quelle

MEDLINE

Beschreibungen/Notizen

• •COVID-19 has a higher severity rate in patient’s diminished immune activity.•COVID-19 organ damage is associated with systemic inflammation and CRS.•COVID-19 immunotherapy demands perception of SARS-CoV-2 immune system interactions.•Findings demonstrated the profound nature of COVID-19 immune dysregulation.•Immunotherapies for COVID-19 is evolving, at least until a vaccine becomes available. Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of international concern” (PHEIC). The infection is highly contagious, has a high mortality rate, and its pathophysiology remains poorly understood. Pulmonary inflammation with substantial lung damage together with generalized immune dysregulation are major components of COVID-19 pathogenesis. The former component, lung damage, seems to be at least in part a consequence of immune dysregulation. Indeed, studies have revealed that immune alteration is not merely an association, as it might occur in systemic infections, but, very likely, the core pathogenic element of COVID-19. In addition, precise management of immune response in COVID-19, i.e. enhancing anti-viral immunity while inhibiting systemic inflammation, may be key to successful treatment. Herein, we have reviewed current evidence related to different aspects of COVID-19 immunology, including innate and adaptive immune responses against the virus and mechanisms of virus-induced immune dysregulation. Considering that current antiviral therapies are chiefly experimental, strategies to do immunotherapy for the management of disease have also been reviewed. Understanding immunology of COVID-19 is important in developing effective therapies as well as diagnostic, and prophylactic strategies for this disease.